These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 20955456)

  • 1. T-cell expression of CD91 - a marker of unresponsiveness to anti-TNF therapy in rheumatoid arthritis.
    Eriksson C; Rantapää-Dahlqvist S; Sundqvist KG
    APMIS; 2010 Nov; 118(11):837-45. PubMed ID: 20955456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synovial expression of IL-15 in rheumatoid arthritis is not influenced by blockade of tumour necrosis factor.
    Ernestam S; af Klint E; Catrina AI; Sundberg E; Engström M; Klareskog L; Ulfgren AK
    Arthritis Res Ther; 2006; 8(1):R18. PubMed ID: 16507118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of peripheral CXCR3 positive T lymphocytes upon treatment of RA patients with TNF-alpha inhibitors.
    Aeberli D; Seitz M; Jüni P; Villiger PM
    Rheumatology (Oxford); 2005 Feb; 44(2):172-5. PubMed ID: 15509629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: association with decreased interferon-gamma production and Toll-like receptor 4 expression.
    Netea MG; Radstake T; Joosten LA; van der Meer JW; Barrera P; Kullberg BJ
    Arthritis Rheum; 2003 Jul; 48(7):1853-7. PubMed ID: 12847679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Messenger ribonucleic acid expression profile in peripheral blood cells from RA patients following treatment with an anti-TNF-alpha monoclonal antibody, infliximab.
    Sekiguchi N; Kawauchi S; Furuya T; Inaba N; Matsuda K; Ando S; Ogasawara M; Aburatani H; Kameda H; Amano K; Abe T; Ito S; Takeuchi T
    Rheumatology (Oxford); 2008 Jun; 47(6):780-8. PubMed ID: 18388148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine and chemokine receptor profile of peripheral blood mononuclear cells during treatment with infliximab in patients with active rheumatoid arthritis.
    Nissinen R; Leirisalo-Repo M; Peltomaa R; Palosuo T; Vaarala O
    Ann Rheum Dis; 2004 Jun; 63(6):681-7. PubMed ID: 15140775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased spontaneous apoptosis of CD4+CD25+ T cells in patients with active rheumatoid arthritis is reduced by infliximab.
    Toubi E; Kessel A; Mahmudov Z; Hallas K; Rozenbaum M; Rosner I
    Ann N Y Acad Sci; 2005 Jun; 1051():506-14. PubMed ID: 16126991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of myeloid cell function and major histocompatibility complex class II expression by tumor necrosis factor.
    Mueller RB; Skapenko A; Grunke M; Wendler J; Stuhlmuller B; Kalden JR; Schulze-Koops H
    Arthritis Rheum; 2005 Feb; 52(2):451-60. PubMed ID: 15692975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B lymphocyte stimulator expression in patients with rheumatoid arthritis treated with tumour necrosis factor alpha antagonists: differential effects between good and poor clinical responders.
    La DT; Collins CE; Yang HT; Migone TS; Stohl W
    Ann Rheum Dis; 2008 Aug; 67(8):1132-8. PubMed ID: 17967830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
    Balanescu A; Radu E; Nat R; Regalia T; Bojinca V; Ionescu R; Balanescu S; Savu C; Predeteanu D
    Int J Clin Pharmacol Res; 2005; 25(1):9-18. PubMed ID: 15864873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
    Mathsson L; Lampa J; Mullazehi M; Rönnelid J
    Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between synovial lymphocyte aggregates and the clinical response to infliximab in rheumatoid arthritis: a prospective study.
    Klaasen R; Thurlings RM; Wijbrandts CA; van Kuijk AW; Baeten D; Gerlag DM; Tak PP
    Arthritis Rheum; 2009 Nov; 60(11):3217-24. PubMed ID: 19877042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High levels of osteoprotegerin and soluble receptor activator of nuclear factor kappa B ligand in serum of rheumatoid arthritis patients and their normalization after anti-tumor necrosis factor alpha treatment.
    Ziolkowska M; Kurowska M; Radzikowska A; Luszczykiewicz G; Wiland P; Dziewczopolski W; Filipowicz-Sosnowska A; Pazdur J; Szechinski J; Kowalczewski J; Rell-Bakalarska M; Maslinski W
    Arthritis Rheum; 2002 Jul; 46(7):1744-53. PubMed ID: 12124857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of candidate genes for rituximab response in rheumatoid arthritis patients by microarray expression profiling in blood cells.
    Julià A; Barceló M; Erra A; Palacio C; Marsal S
    Pharmacogenomics; 2009 Oct; 10(10):1697-708. PubMed ID: 19842941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretreatment cytokine profiles of peripheral blood mononuclear cells and serum from patients with rheumatoid arthritis in different american college of rheumatology response groups to methotrexate.
    Seitz M; Zwicker M; Villiger PM
    J Rheumatol; 2003 Jan; 30(1):28-35. PubMed ID: 12508386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of intra-articular corticosteroids and anti-TNF therapy on neutrophil activation in rheumatoid arthritis.
    Wittkowski H; Foell D; af Klint E; De Rycke L; De Keyser F; Frosch M; Ulfgren AK; Roth J
    Ann Rheum Dis; 2007 Aug; 66(8):1020-5. PubMed ID: 17223658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients.
    Wolfe F; Michaud K
    J Rheumatol; 2004 Nov; 31(11):2115-20. PubMed ID: 15517621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging biologic drugs for the treatment of rheumatoid arthritis.
    Puppo F; Murdaca G; Ghio M; Indiveri F
    Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
    Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
    Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of p38 MAP kinase in CD4+ lymphocytes by infliximab therapy in patients with rheumatoid arthritis.
    Garfield BE; Krahl T; Appel S; Cooper SM; Rincón M
    Clin Immunol; 2005 Aug; 116(2):101-7. PubMed ID: 15914087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.